Search Within

Katherine S Panageas

Formats
  1. Journal Article (313)
  2. Meeting Abstract (177)
  3. Editorial (5)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Review (4)
  7. Book Section (3)
  8. Miscellaneous (1)
Groups
  1. Biostatistics Service (512)
  2. Epidemiology and Biostatistics (512)
  3. Population Sciences Research Program (512)
  4. Department of Medicine (298)
  5. Solid Tumor Oncology Division (256)
  6. GSK Faculty (186)

More Groups

People
  1. Jedd Wolchok (92)
  2. Anne Reiner (90)
  3. Lisa De Angelis (85)
  4. Paul Chapman (77)
  5. Michael Postow (64)
  6. Clifford Hudis (56)

More People

Years
  1. 2025 (8)
  2. 2024 (23)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (34)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (105)
  2. Neuro-Oncology (40)
  3. Clinical Cancer Research (31)
  4. Annals of Surgical Oncology (28)
  5. Cancer (21)
  6. Breast Cancer Research and Treatment (20)

More Publications

Publishers
  1. American Society of Clinical Oncology (118)
  2. Oxford University Press (65)
  3. Springer (65)
  4. American Association for Cancer Research (56)
  5. Wiley Blackwell (38)
  6. American Medical Association (19)

More Publishers

Results (512)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical-pathologic assessment of the clinical sensitivity to single agent taxane (T) therapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Van Poznak, C.; Tan, L.; Panageas, K.; Arroyo, C.; Hudis, C.; Norton, L.; Seidman, A. D.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save
  • Beta- vs alpha-emitter dose-response analysis in patients
    Meeting Abstract

    Sgouros, G.; Ballangrud, A. M.; Hamacher, K. A.; Jurcic, J. G.; Panageas, K. S.; McDevitt, M. R.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Journal of Nuclear Medicine (2000)

    Fulltext@MSK | Save
  • Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide
    Journal Article

    Lewis, J. J.; Janetzki, S.; Schaed, S.; Panageas, K. S.; Wang, S.; Williams, L.; Meyers, M.; Butterworth, L.; Livingston, P. O.; Chapman, P. B.; more...
    International Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts
    Journal Article

    Deckert, P. M.; Jungbluth, A.; Montalto, N.; Clark, M. A.; Finn, R. D.; Williams, C. Jr; Richards, E. C.; Panageas, K. S.; Old, L. J.; Welt, S.
    International Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Vaccination with a bivalent GM2 and GD2 ganglioside conjugate vaccine: A trial comparing doses of GD2-keyhole limpet hemocyanin
    Journal Article

    Chapman, P. B.; Morrisey, D.; Panageas, K. S.; Williams, L.; Lewis, J. J.; Israel, R. J.; Hamilton, W. B.; Livingston, P. O.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21
    Journal Article

    Gilewski, T.; Adluri, S.; Ragupathi, G.; Zhang, S.; Yao, T. J.; Panageas, K.; Moynahan, M.; Houghton, A.; Norton, L.; Livingston, P. O.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: A dose-response study
    Journal Article

    Chapman, P. B.; Morrissey, D. M.; Panageas, K. S.; Hamilton, W. B.; Zhan, C.; Destro, A. N.; Williams, L.; Israel, R. J.; Livingston, P. O.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Interval estimation of the common odds ratio from k(2 x 2) tables under cluster sampling
    Journal Article

    Begg, M. D.; Panageas, K. S.
    Statistics in Medicine (1999)

    Fulltext@MSK | Save
  • A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses
    Journal Article

    Wang, S.; Bartido, S.; Yang, G.; Qin, J.; Moroi, Y.; Panageas, K. S.; Lewis, J. J.; Houghton, A. N.
    Journal of Immunology (1999)

    Fulltext@MSK | Save
  • Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma
    Journal Article

    Chapman, P. B.; Einhorn, L. H.; Meyers, M. L.; Saxman, S.; Destro, A. N.; Panageas, K. S.; Begg, C. B.; Agarwala, S. S.; Schuchter, L. M.; Ernstoff, M. S.; more...
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save